All Posts Tagged: Neurostar

TMS Therapy Shows Long-Term Benefits In Difficult-To-Treat Patients With Depression

NeuroStar TMS therapyThe first successful transcranial magnetic stimulation was performed in 1985 and it has opened doors for a widespread variety of therapy interventions for a multitude of diseases, with depression being the most studied area. Although transcranial magnetic stimulation has been around for over 20 years, it’s only in recent years that it has become a widely acceptable and valuable treatment for major depression.  This is due to investigators worldwide completing more than 30 randomized, controlled clinical trials proving time and time again that TMS Therapy is an effective treatment for depression.[1]

Read More

“How I Finally Beat Depression” – TMS Therapy in Good Housekeeping Magazine

good housekeeping magazineIn this month’s edition of Good Housekeeping magazine we get to meet Carmen, a TMS therapy success story. Carmen’s life was that of the perfect southern belle; she was part of her high school’s cheerleading team in Memphis and was about to head to the national championships. This all changed drastically after she suffered a knee injury that forced her to quit the activity she enjoyed the most and sent her life spiraling out of control and into depression. After two kids, a divorce, and a miscarriage Carmen quietly withdrew from the world.

Read More

Non-Drug Depression Treatment Rapidly and Significantly Improves Disease Symptoms and Quality of Life

─ Percentage of Patients Reporting a Return to Normal Activities More Than Tripled Following Treatment with NeuroStar TMS Therapy® ─

PHILADELPHIA, May 8, 2012 – New data released today at the annual meeting of the AmericanPsychiatric Association show that patients with unipolar, non-psychotic Major Depressive Disorder (MDD) receiving transcranial magnetic stimulation (TMS) with NeuroStar TMS Therapy® achieved significant improvements in both depression symptoms and in quality of life measurements. Overall, 58 percent of patients achieved a positive response to NeuroStar TMS therapy, with 37 percent of patients achieving remission from their depression.After an average of five weeks of NeuroStar treatment, the percentage of patients reporting extreme problems with anxiety and depression decreased by 42.2 percent, demonstrating a reduction in depression symptomatology. For overall treatment effect, the percentage of patients reporting no problems in performing usual activities improved by 30.5 percent.”The improvements we observed show that non-drug therapy with NeuroStar TMS not only reduces the symptomatic suffering of patients, but lessens the disability of depression with important implications for these individuals’ ability to return to functioning effectively at home, in the workplace, and in the community,” said Ian A. Cook, M.D., Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles.

Read More